Guardion Health Sciences (GHSI) Sets New 52-Week Low at $2.00

Guardion Health Sciences Inc (NASDAQ:GHSI) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $2.00 and last traded at $2.50, with a volume of 100 shares. The stock had previously closed at $2.59.

ILLEGAL ACTIVITY WARNING: “Guardion Health Sciences (GHSI) Sets New 52-Week Low at $2.00” was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at

Guardion Health Sciences Company Profile (NASDAQ:GHSI)

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Further Reading: What is the Coverage Ratio?

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with's FREE daily email newsletter.